Parkinson's Disease and α-Synuclein Expression

被引：146

作者：

Devine, Michael J. ^{[1
]}

Gwinn, Katrina ^{[2
]}

Singleton, Andrew ^{[3
]}

Hardy, John ^{[1
]}

机构：

[1] UCL Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England

[2] Baylor Coll Med, Houston, TX 77030 USA

[3] NIA, NIH, Bethesda, MD 20892 USA

来源：

MOVEMENT DISORDERS | 2011年 / 26卷 / 12期

基金：

英国惠康基金; 英国医学研究理事会;

关键词：

Parkinsonism; genetics; alpha-synuclein; MULTIPLE SYSTEM ATROPHY; LEWY BODY; IN-VIVO; SNCA DUPLICATION; GENE DUPLICATION; MOUSE MODEL; NEURODEGENERATIVE DISEASE; DOPAMINERGIC-NEURONS; LOCUS TRIPLICATION; MESSENGER-RNA;

D O I：

10.1002/mds.23948

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

100204 [神经病学];

摘要：

Genetic studies of Parkinson's disease over the last decade or more have revolutionized our understanding of this condition. alpha-Synuclein was the first gene to be linked to Parkinson's disease, and is arguably the most important: the protein is the principal constituent of Lewy bodies, and variation at its locus is the major genetic risk factor for sporadic disease. Intriguingly, duplications and triplications of the locus, as well as point mutations, cause familial disease. Therefore, subtle alterations of alpha-synuclein expression can manifest with a dramatic phenotype. We outline the clinical impact of alpha-synuclein locus multiplications, and the implications that this has for Parkinson's disease pathogenesis. Finally, we discuss potential strategies for disease-modifying therapies for this currently incurable disorder. (C) 2011 Movement Disorder Society

引用

页码：2160 / 2168

页数：9

共 99 条

[1]

Mice lacking α-synuclein display functional deficits in the nigrostriatal dopamine system [J].

Abeliovich, A ;

Schmitz, Y ;

Fariñas, I ;

Choi-Lundberg, D ;

Ho, WH ;

Castillo, PE ;

Shinsky, N ;

Verdugo, JMG ;

Armanini, M ;

Ryan, A ;

Hynes, M ;

Phillips, H ;

Sulzer, D ;

Rosenthal, A .

NEURON, 2000, 25 (01) :239-252

[2]

α-Synuclein gene duplication is present in sporadic Parkinson disease [J].

Ahn, T. -B. ;

Kim, S. Y. ;

Kim, J. Y. ;

Park, S. -S. ;

Lee, D. S. ;

Min, H. J. ;

Kim, Y. K. ;

Kim, S. E. ;

Kim, J. -M. ;

Kim, H. -J. ;

Cho, J. ;

Jeon, B. S. .

NEUROLOGY, 2008, 70 (01) :43-49

[3]

Neural transplantation for the treatment of Parkinson's disease [J].

Björklund, A ;

Dunnett, SB ;

Brundin, P ;

Stoessl, AJ ;

Freed, CR ;

Breeze, RE ;

Levivier, M ;

Peschanski, M ;

Studer, L ;

Barker, R .

LANCET NEUROLOGY, 2003, 2 (07) :437-445

[4]

Staging of brain pathology related to sporadic Parkinson's disease [J].

Braak, H ;

Del Tredici, K ;

Rüb, U ;

de Vos, RAI ;

Steur, ENHJ ;

Braak, E .

NEUROBIOLOGY OF AGING, 2003, 24 (02) :197-211

[5]

α-Synuclein Promotes SNARE-Complex Assembly in Vivo and in Vitro [J].

Burre, Jacqueline ;

Sharma, Manu ;

Tsetsenis, Theodoros ;

Buchman, Vladimir ;

Etherton, Mark R. ;

Suedhof, Thomas C. .

SCIENCE, 2010, 329 (5999) :1663-1667

[6]

α-synuclein locus duplication as a cause of familial Parkinson's disease [J].

Chartier-Harlin, MC ;

Kachergus, J ;

Roumier, C ;

Mouroux, V ;

Douay, X ;

Lincoln, S ;

Levecque, C ;

Larvor, L ;

Andrieux, J ;

Hulihan, M ;

Waucquier, N ;

Defebvre, L ;

Amouyel, P ;

Farrer, M ;

Destée, A .

LANCET, 2004, 364 (9440) :1167-1169

[7]

Effect of allelic variation at the NACP-Rep1 repeat upstream of the α-synuclein gene (SNCA) on transcription in a cell culture luciferase reporter system [J].

Chiba-Falek, O ;

Nussbaum, RL .

HUMAN MOLECULAR GENETICS, 2001, 10 (26) :3101-3109

[8]

Levels of alpha-synuclein mRNA in sporadic Parkinson disease patients [J].

Chiba-Falek, Ornit ;

Lopez, Grisel J. ;

Nussbaum, Robert L. .

MOVEMENT DISORDERS, 2006, 21 (10) :1703-1708

[9]

Mitochondrial alpha-synuclein accumulation impairs complex I function in dopaminergic neurons and results in increased mitophagy in vivo [J].

Chinta, Shankar J. ;

Mallajosyula, Jyothi K. ;

Rane, Anand ;

Andersen, Julie K. .

NEUROSCIENCE LETTERS, 2010, 486 (03) :235-239

[10]

Age-associated increases of α-synuclein in monkeys and humans are associated with nigrostriatal dopamine depletion:: Is this the target for Parkinson's disease? [J].

Chu, Yaping ;

Kordower, Jeffrey H. .

NEUROBIOLOGY OF DISEASE, 2007, 25 (01) :134-149

← 1 2 3 4 5 6 7 8 9 10 →